HEADER TRANSCRIPTION 05-JAN-15 4XHD TITLE STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN WITH TITLE 2 COMPOUND-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR SUBFAMILY 1 GROUP I MEMBER 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ORPHAN NUCLEAR RECEPTOR PAR1,ORPHAN NUCLEAR RECEPTOR PXR, COMPND 5 PREGNANE X RECEPTOR,STEROID AND XENOBIOTIC RECEPTOR,SXR; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1I2, PXR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PCO7 KEYWDS PREGNANE X RECEPTOR, PXR, LIGAND BINDING DOMAIN, STEROID RECEPTOR KEYWDS 2 COACTIVATOR-1; CCR1, CHEMOKINE RECEPTOR-1; ADNECTIN NR, NUCLEAR KEYWDS 3 RECEPTOR; AF, ACTIVATION FUNCTION; CYP, CYTOCHROME P450; MDR1, KEYWDS 4 MULTI-DRUG RESISTANCE GENE-1., TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR J.A.KHAN,D.M.CAMAC REVDAT 4 28-FEB-24 4XHD 1 JRNL REMARK REVDAT 3 30-SEP-15 4XHD 1 JRNL REVDAT 2 25-FEB-15 4XHD 1 JRNL REVDAT 1 28-JAN-15 4XHD 0 JRNL AUTH J.A.KHAN,D.M.CAMAC,S.LOW,A.J.TEBBEN,D.L.WENSEL,M.C.WRIGHT, JRNL AUTH 2 J.SU,V.JENNY,R.D.GUPTA,M.RUZANOV,K.A.RUSSO,A.BELL,Y.AN, JRNL AUTH 3 J.W.BRYSON,M.GAO,P.GAMBHIRE,E.T.BALDWIN,D.GARDNER, JRNL AUTH 4 C.L.CAVALLARO,J.V.DUNCIA,J.HYNES JRNL TITL DEVELOPING ADNECTINS THAT TARGET SRC CO-ACTIVATOR BINDING TO JRNL TITL 2 PXR: A STRUCTURAL APPROACH TOWARD UNDERSTANDING PROMISCUITY JRNL TITL 3 OF PXR. JRNL REF J.MOL.BIOL. V. 427 924 2015 JRNL REFN ESSN 1089-8638 JRNL PMID 25579995 JRNL DOI 10.1016/J.JMB.2014.12.022 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.S.GARDNER,J.B.SANTELLA,J.V.DUNCIA,P.H.CARTER,T.G.DHAR, REMARK 1 AUTH 2 H.WU,W.GUO,C.CAVALLARO,K.VAN KIRK,M.YARDE,S.W.BRICENO, REMARK 1 AUTH 3 R.R.GRAFSTROM,R.LIU,S.R.PATEL,A.J.TEBBEN,D.CAMAC,J.KHAN, REMARK 1 AUTH 4 A.WATSON,G.YANG,A.ROSE,W.R.FOSTER,M.E.CVIJIC,P.DAVIES, REMARK 1 AUTH 5 J.HYNES REMARK 1 TITL THE DISCOVERY OF BMS-457, A POTENT AND SELECTIVE CCR1 REMARK 1 TITL 2 ANTAGONIST. REMARK 1 REF BIOORG.MED.CHEM.LETT. V. 23 3833 2013 REMARK 1 REFN ESSN 1464-3405 REMARK 1 PMID 23707259 REMARK 1 DOI 10.1016/J.BMCL.2013.04.079 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 14643 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 737 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 7 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.59 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.34 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2944 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2208 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2775 REMARK 3 BIN R VALUE (WORKING SET) : 0.2190 REMARK 3 BIN FREE R VALUE : 0.2511 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.74 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 169 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2176 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 68 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 49.61 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.08 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.36110 REMARK 3 B22 (A**2) : -1.36110 REMARK 3 B33 (A**2) : 2.72220 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.291 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.321 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.231 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.304 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.228 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.939 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.918 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2265 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3056 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 818 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 55 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 329 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2265 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 283 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2674 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.07 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.68 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.80 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4XHD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JAN-15. REMARK 100 THE DEPOSITION ID IS D_1000205689. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-APR-08 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14661 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 10.40 REMARK 200 R MERGE (I) : 0.10100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 10.60 REMARK 200 R MERGE FOR SHELL (I) : 0.68500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M IMIDAZOLE PH 7.8, 8 REMARK 280 -10%(V/V)ISOPROPANOL. APO CRYSTAL WAS SOAKED WITH 5 MM COMPOUND REMARK 280 1 AND CRYSTALS HARVESTED NEXT DAY USING 32% ETHYLENE GLYCOL AS REMARK 280 CRYOPROTECTANT, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.78200 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 45.73800 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 45.73800 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 64.17300 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 45.73800 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 45.73800 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 21.39100 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 45.73800 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 45.73800 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 64.17300 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 45.73800 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 45.73800 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 21.39100 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 42.78200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: CHAINS A REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2480 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25810 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -42.78200 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 120 REMARK 465 LYS A 121 REMARK 465 LYS A 122 REMARK 465 HIS A 123 REMARK 465 HIS A 124 REMARK 465 HIS A 125 REMARK 465 HIS A 126 REMARK 465 HIS A 127 REMARK 465 HIS A 128 REMARK 465 GLY A 129 REMARK 465 SER A 130 REMARK 465 GLU A 131 REMARK 465 ARG A 132 REMARK 465 THR A 133 REMARK 465 GLY A 134 REMARK 465 THR A 135 REMARK 465 GLN A 136 REMARK 465 PRO A 137 REMARK 465 LEU A 138 REMARK 465 GLY A 139 REMARK 465 VAL A 140 REMARK 465 GLN A 141 REMARK 465 SER A 179 REMARK 465 SER A 180 REMARK 465 GLY A 181 REMARK 465 CYS A 182 REMARK 465 GLU A 183 REMARK 465 LEU A 184 REMARK 465 PRO A 185 REMARK 465 GLU A 186 REMARK 465 SER A 187 REMARK 465 LEU A 188 REMARK 465 GLN A 189 REMARK 465 ALA A 190 REMARK 465 PRO A 191 REMARK 465 SER A 192 REMARK 465 ARG A 193 REMARK 465 GLU A 194 REMARK 465 GLU A 195 REMARK 465 ALA A 196 REMARK 465 ASP A 310 REMARK 465 THR A 311 REMARK 465 ALA A 312 REMARK 465 GLY A 313 REMARK 465 THR A 432 REMARK 465 GLY A 433 REMARK 465 SER A 434 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 170 CE NZ REMARK 470 LYS A 210 CE NZ REMARK 470 HIS A 359 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A 360 CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY A 233 N - CA - C ANGL. DEV. = 38.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 231 50.42 -143.73 REMARK 500 GLU A 235 -30.83 -38.35 REMARK 500 CYS A 301 65.49 -102.46 REMARK 500 PHE A 315 -113.99 67.41 REMARK 500 PHE A 349 59.15 -92.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 SER A 231 GLY A 232 -115.97 REMARK 500 GLY A 232 GLY A 233 118.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 40U A 502 DBREF 4XHD A 130 434 UNP O75469 NR1I2_HUMAN 153 457 SEQADV 4XHD MET A 120 UNP O75469 INITIATING METHIONINE SEQADV 4XHD LYS A 121 UNP O75469 EXPRESSION TAG SEQADV 4XHD LYS A 122 UNP O75469 EXPRESSION TAG SEQADV 4XHD HIS A 123 UNP O75469 EXPRESSION TAG SEQADV 4XHD HIS A 124 UNP O75469 EXPRESSION TAG SEQADV 4XHD HIS A 125 UNP O75469 EXPRESSION TAG SEQADV 4XHD HIS A 126 UNP O75469 EXPRESSION TAG SEQADV 4XHD HIS A 127 UNP O75469 EXPRESSION TAG SEQADV 4XHD HIS A 128 UNP O75469 EXPRESSION TAG SEQADV 4XHD GLY A 129 UNP O75469 EXPRESSION TAG SEQRES 1 A 315 MET LYS LYS HIS HIS HIS HIS HIS HIS GLY SER GLU ARG SEQRES 2 A 315 THR GLY THR GLN PRO LEU GLY VAL GLN GLY LEU THR GLU SEQRES 3 A 315 GLU GLN ARG MET MET ILE ARG GLU LEU MET ASP ALA GLN SEQRES 4 A 315 MET LYS THR PHE ASP THR THR PHE SER HIS PHE LYS ASN SEQRES 5 A 315 PHE ARG LEU PRO GLY VAL LEU SER SER GLY CYS GLU LEU SEQRES 6 A 315 PRO GLU SER LEU GLN ALA PRO SER ARG GLU GLU ALA ALA SEQRES 7 A 315 LYS TRP SER GLN VAL ARG LYS ASP LEU CYS SER LEU LYS SEQRES 8 A 315 VAL SER LEU GLN LEU ARG GLY GLU ASP GLY SER VAL TRP SEQRES 9 A 315 ASN TYR LYS PRO PRO ALA ASP SER GLY GLY LYS GLU ILE SEQRES 10 A 315 PHE SER LEU LEU PRO HIS MET ALA ASP MET SER THR TYR SEQRES 11 A 315 MET PHE LYS GLY ILE ILE SER PHE ALA LYS VAL ILE SER SEQRES 12 A 315 TYR PHE ARG ASP LEU PRO ILE GLU ASP GLN ILE SER LEU SEQRES 13 A 315 LEU LYS GLY ALA ALA PHE GLU LEU CYS GLN LEU ARG PHE SEQRES 14 A 315 ASN THR VAL PHE ASN ALA GLU THR GLY THR TRP GLU CYS SEQRES 15 A 315 GLY ARG LEU SER TYR CYS LEU GLU ASP THR ALA GLY GLY SEQRES 16 A 315 PHE GLN GLN LEU LEU LEU GLU PRO MET LEU LYS PHE HIS SEQRES 17 A 315 TYR MET LEU LYS LYS LEU GLN LEU HIS GLU GLU GLU TYR SEQRES 18 A 315 VAL LEU MET GLN ALA ILE SER LEU PHE SER PRO ASP ARG SEQRES 19 A 315 PRO GLY VAL LEU GLN HIS ARG VAL VAL ASP GLN LEU GLN SEQRES 20 A 315 GLU GLN PHE ALA ILE THR LEU LYS SER TYR ILE GLU CYS SEQRES 21 A 315 ASN ARG PRO GLN PRO ALA HIS ARG PHE LEU PHE LEU LYS SEQRES 22 A 315 ILE MET ALA MET LEU THR GLU LEU ARG SER ILE ASN ALA SEQRES 23 A 315 GLN HIS THR GLN ARG LEU LEU ARG ILE GLN ASP ILE HIS SEQRES 24 A 315 PRO PHE ALA THR PRO LEU MET GLN GLU LEU PHE GLY ILE SEQRES 25 A 315 THR GLY SER HET GOL A 501 6 HET 40U A 502 29 HETNAM GOL GLYCEROL HETNAM 40U N-{(2R)-1-[(4S)-4-(4-CHLOROPHENYL)-4-HYDROXY-3,3- HETNAM 2 40U DIMETHYLPIPERIDIN-1-YL]-3-METHYL-1-OXOBUTAN-2-YL}-2- HETNAM 3 40U CYCLOPROPYLACETAMIDE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 GOL C3 H8 O3 FORMUL 3 40U C23 H33 CL N2 O3 FORMUL 4 HOH *68(H2 O) HELIX 1 AA1 THR A 144 PHE A 162 1 19 HELIX 2 AA2 LYS A 198 SER A 208 1 11 HELIX 3 AA3 GLY A 233 SER A 238 5 6 HELIX 4 AA4 LEU A 239 ILE A 261 1 23 HELIX 5 AA5 ILE A 261 ASP A 266 1 6 HELIX 6 AA6 PRO A 268 THR A 290 1 23 HELIX 7 AA7 GLU A 321 LEU A 333 1 13 HELIX 8 AA8 HIS A 336 PHE A 349 1 14 HELIX 9 AA9 GLN A 358 ARG A 381 1 24 HELIX 10 AB1 GLN A 383 ARG A 387 5 5 HELIX 11 AB2 PHE A 388 HIS A 418 1 31 HELIX 12 AB3 THR A 422 PHE A 429 1 8 SHEET 1 AA1 5 VAL A 222 TYR A 225 0 SHEET 2 AA1 5 VAL A 211 ARG A 216 -1 N LEU A 213 O TYR A 225 SHEET 3 AA1 5 LEU A 304 LEU A 308 -1 O CYS A 307 N SER A 212 SHEET 4 AA1 5 THR A 298 CYS A 301 -1 N TRP A 299 O TYR A 306 SHEET 5 AA1 5 PHE A 292 ASN A 293 -1 N ASN A 293 O THR A 298 SITE 1 AC1 8 THR A 161 ASP A 163 PHE A 166 TYR A 249 SITE 2 AC1 8 MET A 250 GLY A 253 ARG A 287 HOH A 664 SITE 1 AC2 11 VAL A 211 MET A 243 GLN A 285 PHE A 288 SITE 2 AC2 11 TRP A 299 TYR A 306 MET A 323 HIS A 407 SITE 3 AC2 11 PHE A 420 HOH A 624 HOH A 656 CRYST1 91.476 91.476 85.564 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010932 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010932 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011687 0.00000